Cargando…
Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents
Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve e...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625475/ https://www.ncbi.nlm.nih.gov/pubmed/34835760 http://dx.doi.org/10.3390/nano11112996 |
_version_ | 1784606430485020672 |
---|---|
author | Ljubimova, Julia Y. Ramesh, Arshia Israel, Liron L. Holler, Eggehard |
author_facet | Ljubimova, Julia Y. Ramesh, Arshia Israel, Liron L. Holler, Eggehard |
author_sort | Ljubimova, Julia Y. |
collection | PubMed |
description | Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve effortless targeted delivery into deep tissue. The design of small biopolymers for deep tissue targeted delivery of multiple imaging agents and therapeutics (mini-nano carriers) emphasizes linear flexible polymer platforms with a hydrodynamic diameter of 4 nm to 10 nm, geometrically favoring dynamic juxtaposition of ligands to host receptors, and economic drug content. Platforms of biodegradable, non-toxic poly(β-l-malic acid) of this size carrying multiple chemically bound, optionally nature-derived or synthetic affinity peptides and drugs for a variety of purposes are described in this review with specific examples. The size, shape, and multiple attachments to membrane sites accelerate vascular escape and fast blood clearance, as well as the increase in medical treatment and contrasts for tissue imaging. High affinity antibodies routinely considered for targeting, such as the brain through the blood–brain barrier (BBB), are replaced by moderate affinity binding peptides (vectors), which penetrate at high influxes not achievable by antibodies. |
format | Online Article Text |
id | pubmed-8625475 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86254752021-11-27 Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents Ljubimova, Julia Y. Ramesh, Arshia Israel, Liron L. Holler, Eggehard Nanomaterials (Basel) Review Research has increasingly focused on the delivery of high, often excessive amounts of drugs, neglecting negative aspects of the carrier’s physical preconditions and biocompatibility. Among them, little attention has been paid to “small but beautiful” design of vehicle and multiple cargo to achieve effortless targeted delivery into deep tissue. The design of small biopolymers for deep tissue targeted delivery of multiple imaging agents and therapeutics (mini-nano carriers) emphasizes linear flexible polymer platforms with a hydrodynamic diameter of 4 nm to 10 nm, geometrically favoring dynamic juxtaposition of ligands to host receptors, and economic drug content. Platforms of biodegradable, non-toxic poly(β-l-malic acid) of this size carrying multiple chemically bound, optionally nature-derived or synthetic affinity peptides and drugs for a variety of purposes are described in this review with specific examples. The size, shape, and multiple attachments to membrane sites accelerate vascular escape and fast blood clearance, as well as the increase in medical treatment and contrasts for tissue imaging. High affinity antibodies routinely considered for targeting, such as the brain through the blood–brain barrier (BBB), are replaced by moderate affinity binding peptides (vectors), which penetrate at high influxes not achievable by antibodies. MDPI 2021-11-08 /pmc/articles/PMC8625475/ /pubmed/34835760 http://dx.doi.org/10.3390/nano11112996 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ljubimova, Julia Y. Ramesh, Arshia Israel, Liron L. Holler, Eggehard Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title | Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title_full | Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title_fullStr | Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title_full_unstemmed | Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title_short | Small-Sized Co-Polymers for Targeted Delivery of Multiple Imaging and Therapeutic Agents |
title_sort | small-sized co-polymers for targeted delivery of multiple imaging and therapeutic agents |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8625475/ https://www.ncbi.nlm.nih.gov/pubmed/34835760 http://dx.doi.org/10.3390/nano11112996 |
work_keys_str_mv | AT ljubimovajuliay smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents AT ramesharshia smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents AT israellironl smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents AT hollereggehard smallsizedcopolymersfortargeteddeliveryofmultipleimagingandtherapeuticagents |